A randomized, double-blinded controlled trial (RCT) of a new whole IgG, equine antivenom compared to the currently used F(ab’)2 CSL taipan antivenom, for the treatment of Papuan taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1033977]

Researchers: Dr Kenneth Winkel (Principal investigator) , Dr David Williams , Dr Simon Jensen , E/Pr David Warrell

Brief description Snakebite is very common in Papua New Guinea (PNG), and many bites are caused by the Papuan taipan, a highly venomous snake found in the southern PNG savannah's. Current antivenom is expensive (US$1500) and many patients do not receive optimal treatment. We will conduct a randomised controlled trial of a new, low cost taipan antivenom developed specifically for PNG. The safety and efficacy of the new antivenom is compared to the existing product to determine if it is a suitable alternative.

Funding Amount $AUD 1,453,073.71

Funding Scheme Project Grants

Notes New Investigator Grant

Subjects

Identifiers

nhmrc : 1033977
PURL : https://purl.org/au-research/grants/nhmrc/1033977

A randomized, double-blinded controlled trial (RCT) of a new whole IgG, equine antivenom compared to the currently used F(ab’)2 CSL taipan antivenom, for the treatment of Papuan taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. [ 2012 - 2015 ]

Research Grant

Related Organisations

Related People